ESC 365 - RNA interference - Building oligonucleotides as therapeutics

ESC Premium Access

RNA interference - Building oligonucleotides as therapeutics

Session: Insights and innovation - Can we alter the course of atherosclerotic cardiovascular disease?

Topic: Treatment

Speaker: Mr D. Corey (Dallas, US)

Sponsored by the Medicines Company

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Mr David Corey

Dallas (United States of America)

1 presentation

0 follower

5 more presentations in this session

Introduction and purpose

Speaker: Doctor B. Berkowitz (New York, US)

LDL-C: The race to the bottom

Speaker: Professor E. Braunwald (Boston, US)

Cumulative exposure - Estimating the benefits of intervention

Speaker: Professor B. Ference (Cambridge, GB)

With recent news - here's what's possible

Speaker: Professor J. Kastelein (Amsterdam, NL)

Panel and audience questions and answers

Speaker: Doctor B. Berkowitz (New York, US)

Access the full session

Insights and innovation - Can we alter the course of atherosclerotic cardiovascular disease?

Speakers: Mr D. Corey, Doctor B. Berkowitz, Professor E. Braunwald, Professor B. Ference, Professor J. Kastelein...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources